Earnings
iQIYI Returns To RMB25.0 Million Adjusted Operating Profit While Revenue Falls 10%
Lower content costs and growing ad sales helped the streaming business, but membership revenue fell 6%.
Product + growth @TheBullished. I build the software that writes the stories you read, and get them in front of as many people as possible.
Earnings
Lower content costs and growing ad sales helped the streaming business, but membership revenue fell 6%.
Earnings
Manufacturing spending fell as Larimar increased commercial preparations for nomlabofusp, its experimental Friedreich’s ataxia treatment.
SEC Filings
Baxfendy could become the EU's first aldosterone synthase inhibitor for patients whose blood pressure remains uncontrolled on other medicines.
SEC Filings
Initial breast-cancer clinical data are expected in the second half of 2027, with research spending lower after earlier cuts.
SEC Filings
PEMGARDA sales rose 18%, but its emergency authorization is due to end in mid-2027.
SEC Filings
The treatment expands Imfinzi's reach to patients unable or unwilling to take cisplatin, but severe adverse events were more common.
Deals
The completed merger brings 2.2 million utility customers under one parent, with new finance and integration chiefs.
SEC Filings
Subsidiaries borrowed $600 million Friday, and the aircraft-engine service company is seeking more revolving credit.
Deals
Each NorthWestern share converts into a right to 0.98 parent shares, with Bright Horizon scheduled to trade on the NYSE under HZN Monday.
SEC Filings
The rare-disease treatment improved patients’ daily activities versus placebo, with benefits starting in week one.
Earnings
The food and facilities services company raised its quarterly dividend 17% and expects further sales and adjusted earnings growth.
SEC Filings
New common shares account for about 19% of post-offering shares as the company prepares for regulatory discussions.